HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keragen implant
injectable collagen used to treat foot ulcers
Networked:
3
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Macromolecular Substances: 97
Polymers: 13051
Biopolymers: 773
Collagen: 52417
Keragen implant: 3
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Scleroproteins: 74
Extracellular Matrix Proteins: 3148
Collagen: 52417
Keragen implant: 3
Organic Chemicals: 133
Aldehydes: 2153
Glutaral: 1207
Keragen implant: 3
Related Diseases
1.
Pain (Aches)
11/01/1986 - "
Thus, these results indicate that subdermal injection of Keragen implant can provide significant reduction in the pain and keratoses associated with heloma durum and heloma molle.
"
11/01/1986 - "
The incidence of pain, keratoses, and both pain and keratoses among Keragen implant-treated sites remained significantly lower than among control sites for up to 12 months after treatment.
"
11/01/1986 - "
In this study, glutaraldehyde cross-linked collagen (Keragen implant) was injected subdermally beneath heloma durum and heloma molle for the relief of both the pain and keratoses associated with these lesions.
"
07/01/1988 - "
Thus, these results indicate that subdermal injection of Keragen implant collagen can provide significant retardation in the formation of keratosis and reduction in the pain associated with tylomas.
"
07/01/1988 - "
Glutaraldehyde cross-linked collagen, Keragen implant, was injected subdermally beneath tylomas for the relief of both the pain and keratoses associated with these lesions.
"
2.
Keratosis
11/01/1986 - "
Thus, these results indicate that subdermal injection of Keragen implant can provide significant reduction in the pain and keratoses associated with heloma durum and heloma molle.
"
11/01/1986 - "
The incidence of pain, keratoses, and both pain and keratoses among Keragen implant-treated sites remained significantly lower than among control sites for up to 12 months after treatment.
"
11/01/1986 - "
In this study, glutaraldehyde cross-linked collagen (Keragen implant) was injected subdermally beneath heloma durum and heloma molle for the relief of both the pain and keratoses associated with these lesions.
"
07/01/1988 - "
Thus, these results indicate that subdermal injection of Keragen implant collagen can provide significant retardation in the formation of keratosis and reduction in the pain associated with tylomas.
"
07/01/1988 - "
Glutaraldehyde cross-linked collagen, Keragen implant, was injected subdermally beneath tylomas for the relief of both the pain and keratoses associated with these lesions.
"
3.
Ulcer
11/01/1987 - "
A new injectable biomaterial, Keragen Implant, was evaluated on two patients with bilateral diabetic ulcers.
"
Related Drugs and Biologics
1.
glutaraldehyde-cross-linked collagen
2.
Collagen
3.
Biocompatible Materials (Biomaterials)
Related Therapies and Procedures
1.
Injections
2.
Aftercare (After-Treatment)